Taken together, these data show that inhibition of Anxa1+ DANs is sufficient to drive early PD-like motor symptoms in movement speed (bradykinesia), movement vigor, and tremor, but not sufficient to cause akinesia. Here, ANXA1 is linked to Parkinson disease.